CA2093919A1 - Hepatitis c virus antibody - Google Patents

Hepatitis c virus antibody

Info

Publication number
CA2093919A1
CA2093919A1 CA002093919A CA2093919A CA2093919A1 CA 2093919 A1 CA2093919 A1 CA 2093919A1 CA 002093919 A CA002093919 A CA 002093919A CA 2093919 A CA2093919 A CA 2093919A CA 2093919 A1 CA2093919 A1 CA 2093919A1
Authority
CA
Canada
Prior art keywords
antibody
plasma
virus
hepatitis
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002093919A
Other languages
English (en)
French (fr)
Inventor
Mahlon F. Miller
Richard R. Lesniewski
David A. Peterson
Warren H. Bryce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2093919A1 publication Critical patent/CA2093919A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002093919A 1990-10-12 1991-10-09 Hepatitis c virus antibody Abandoned CA2093919A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59681190A 1990-10-12 1990-10-12
US596,811 1990-10-12

Publications (1)

Publication Number Publication Date
CA2093919A1 true CA2093919A1 (en) 1992-04-13

Family

ID=24388816

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002093919A Abandoned CA2093919A1 (en) 1990-10-12 1991-10-09 Hepatitis c virus antibody

Country Status (7)

Country Link
EP (1) EP0552297A1 (enExample)
JP (1) JPH06502075A (enExample)
KR (1) KR930702506A (enExample)
AU (1) AU663064B2 (enExample)
CA (1) CA2093919A1 (enExample)
TW (1) TW216797B (enExample)
WO (1) WO1992007001A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702507A (ko) * 1990-11-07 1993-09-09 챨스 엠. 브록 C형 간염 바이러스에 대한 모노클로날 항체 및 이의 사용 방법
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ES2543630T3 (es) 2003-04-01 2015-08-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Anticuerpos dirigidos contra el complejo E1E2 del virus de la hepatitis C y sus epítopos
US8551484B2 (en) 2007-02-21 2013-10-08 University Of Massachusetts Human antibodies against hepatitis C virus (HCV) and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado
AU632271B2 (en) * 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver

Also Published As

Publication number Publication date
WO1992007001A1 (en) 1992-04-30
JPH06502075A (ja) 1994-03-10
TW216797B (enExample) 1993-12-01
AU663064B2 (en) 1995-09-28
EP0552297A4 (enExample) 1994-02-09
AU8945791A (en) 1992-05-20
EP0552297A1 (en) 1993-07-28
KR930702506A (ko) 1993-09-09

Similar Documents

Publication Publication Date Title
DE69331845T2 (de) Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen
DE69131488T2 (de) Kombinationen der Hepatitis-C-Virus (HCV) Antigene zur Verwendung in Immuntests für Anti-HCV-Antikörper
EP0484787B1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DE69434117T2 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
US3951937A (en) Large scale purification of hepatitis type B antigen using polyethylene glycol
US3994870A (en) Purification of hepatitis B surface antigen
JP2003501661A (ja) Ｎｓ１糖タンパク質を用いるフラビウイルスの早期検出
CA1194792A (en) Non-a, non-b hepatitis-associated monoclonal antibody and diagnostic reagent
DE69532062T2 (de) Immuntests von nicht-A, nicht-B Hepatitisvirus-verwandten Antigenen, monoklonale Antikörper und diese synthetisierende Hybridome
US7108967B2 (en) Hepatitis C viral antigen immunoassay detection systems
Hirashima et al. Regulatory role of IgE-binding factors from rat T lymphocytes. IV. Formation of IgE-binding factors in rats treated with complete Freund's adjuvant.
EP0124896B1 (de) Verfahren zur Gewinnung von Viren bzw. Virusantigenen und deren Anwendung in Diagnose und Therapie (Impfstoff)
JPH0250426B2 (enExample)
CA1259921A (en) Non-a non-b hepatitis antigens
EP0186360A2 (en) Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
AU663064B2 (en) Hepatitis C virus antibody
CA1177749A (en) Non-a, non-b hepatitis-associated antibody and detection reagent
US4132767A (en) Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US4745053A (en) Process for producing human interferon and method for assaying the interferon productivity of blood
Rizzetto et al. A radioimmunoassay for HBcAg in the sera of HBsAg carriers: Serum HBcAg, serum DNA polymerase activity, and liver HBcAg immunofluorescence as markers of chronic liver disease
Schrempf‐Decker et al. Biological and immunological characterization of a human liver immunoregulatory protein
DE19500394C2 (de) Peptide zur Diagnose, zum Nachweis und zur Prävention von Hepatitis C Virus (HCV)-Infektionen
US5162224A (en) Monoclonal antibodies specific for b cells and htlv-i transformed t cells
US5407811A (en) Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies
DE4112743C2 (de) Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued